Ligand · E14
E14 · (4R)-3-[(2S,3S)-3-[[(2S)-2-[[(2S)-2-azanyl-2-phenyl-ethanoyl]amino]-3,3-dimethyl-butanoyl]amino]-2-hydroxy-4-phenyl-but anoyl]-5,5-dimethyl-N-(2-methylpropyl)-1,3-thiazolidine-4-carboxamide
E14, (4R)-3-[(2S,3S)-3-[[(2S)-2-[[(2S)-2-azanyl-2-phenyl-ethanoyl]amino]-3,3-dimethyl-butanoyl]amino]-2-hydroxy-4-phenyl-but anoyl]-5,5-dimethyl-N-(2-methylpropyl)-1,3-thiazolidine-4-carboxamide (C34 H49 N5 O5 S, 639.9 g/mol), in the…
- Component
- E14
- Formula
- C34 H49 N5 O5 S
- Class
- ligand
- Structures
- 2
- PDB entries
- 1
Binding sites
E14 in 2 structures; the first of them:
- 3LIQ · Crystal Structure of HTLV protease complexed with the inhibitor, KNI-10673 · E14 B117 · binds ARG10, LEU30, ASP32, GLY34, ALA35, VAL39, VAL56, LEU57 and 20 more
- 3LIQ · Crystal structure of HTLV protease complexed with the inhibitor, kni- 10673 · E14 B117 · binds ARG10, LEU30, ASP32, GLY34, ALA35, VAL39, VAL56, LEU57 and 20 more
Residues it binds most
LEU 2, ALA 2, GLY 2, VAL 2, ASP 2, ILE 2, TRP 2, ARG 2, MET 2, PHE 2 (residue and the binding sites it lines).
GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.